Search alternatives:
nm decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
w decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 301 - 320 results of 65,267 for search '(( 5 ((nm decrease) OR (a decrease)) ) OR ( 5 ((w decrease) OR (we decrease)) ))', query time: 1.18s Refine Results
  1. 301
    Effects of HWHF on (A-F) sucrose content in the gut after oral sucrose loading in high fat fed rats. Rats were fasted for 24 h before the oral administration of sucrose solution (2.5 g/kg b.w.) with or without HWHF (250 mg/5ml/kg, b.w.).

    Effects of HWHF on (A-F) sucrose content in the gut after oral sucrose loading in high fat fed rats. Rats were fasted for 24 h before the oral administration of sucrose solution (2... by Prawej Ansari (12191266)

    Published 2022
    Save to List
    Saved in:
  2. 302
    MMR mutants show decreased mating-type silencing.

    MMR mutants show decreased mating-type silencing. by Qian Liu (135614)

    Published 2020
    “…<p><b>(A)</b> MMR mutants have increased growth rates in SD-Ura liquid medium. …”
    Save to List
    Saved in:
  3. 303
    Table_1_v2_A long waiting time from diagnosis to treatment decreases the survival of non-small cell lung cancer patients with stage IA1: A retrospective study.docx

    Table_1_v2_A long waiting time from diagnosis to treatment decreases the survival of non-small cell lung cancer patients with stage IA1: A retrospective study.docx by Bin Liu (5899)

    Published 2022
    “…After adjusting for other confounders, the waiting time was identified as an independent prognostic factor.</p>Conclusions<p>A long waiting time before treatment may decrease the survival of stage IA1 NSCLC patients. …”
    Save to List
    Saved in:
  4. 304
    Multi-way sensitivity analysis on transmission rate, CD4 count at diagnosis, and ART costs in a model-based analysis of Immediate ART initiation in Côte d’Ivoire.

    Multi-way sensitivity analysis on transmission rate, CD4 count at diagnosis, and ART costs in a model-based analysis of Immediate ART initiation in Côte d’Ivoire. by Eric N. Ouattara (6890174)

    Published 2019
    Save to List
    Saved in:
  5. 305
    Infectiousness profiles of SARS-CoV-1 and SARS-CoV-2.

    Infectiousness profiles of SARS-CoV-1 and SARS-CoV-2. by Matteo Serafino (11599593)

    Published 2022
    Save to List
    Saved in:
  6. 306
    Image4_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg

    Image4_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  7. 307
    Image2_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg

    Image2_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  8. 308
    Image6_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg

    Image6_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  9. 309
    Image1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg

    Image1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  10. 310
    Image3_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg

    Image3_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  11. 311
    Image7_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg

    Image7_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  12. 312
    Table1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.xlsx

    Table1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.xlsx by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  13. 313
    CcnA mutation of Loop A decreases the interaction with the 5′ UTR of P2-<i>ctrA</i> mRNA and 5′ UTR of <i>gcrA</i> mRNA.

    CcnA mutation of Loop A decreases the interaction with the 5′ UTR of P2-<i>ctrA</i> mRNA and 5′ UTR of <i>gcrA</i> mRNA. by Wanassa Beroual (5314028)

    Published 2022
    Save to List
    Saved in:
  14. 314
    Fig 5 -

    Fig 5 - by Zhi Zhang (55283)

    Published 2023
    Save to List
    Saved in:
  15. 315
    Dcp1a protein levels are decreased by KapB expression and Torin treatment.

    Dcp1a protein levels are decreased by KapB expression and Torin treatment. by Carolyn-Ann Robinson (13297009)

    Published 2023
    Save to List
    Saved in:
  16. 316
    Reversion to susceptibility was consistent with decreasing relative <i>vanA</i> copy number.

    Reversion to susceptibility was consistent with decreasing relative <i>vanA</i> copy number. by Samuel E. Blechman (19506884)

    Published 2024
    Save to List
    Saved in:
  17. 317
    An enhanced clot growth rate before in vitro fertilization decreases the probability of pregnancy

    An enhanced clot growth rate before in vitro fertilization decreases the probability of pregnancy by A. N. Balandina (6729380)

    Published 2019
    Save to List
    Saved in:
  18. 318
    Knockdown of ABCG2 in PANC-1 clone cells increases 5-ALA staining.

    Knockdown of ABCG2 in PANC-1 clone cells increases 5-ALA staining. by Noriko Kawai (6694010)

    Published 2019
    Save to List
    Saved in:
  19. 319
    Activating cAMP synthesis decreases liberation of propionyl-CoA from cholesterol.

    Activating cAMP synthesis decreases liberation of propionyl-CoA from cholesterol. by Kaley M. Wilburn (12060476)

    Published 2022
    Save to List
    Saved in:
  20. 320
    Changes in cyanobacteria fluorescence with 75 μg/mL H<sub>2</sub>O<sub>2</sub> for 5, 8, 17 and 24 days.

    Changes in cyanobacteria fluorescence with 75 μg/mL H<sub>2</sub>O<sub>2</sub> for 5, 8, 17 and 24 days. by Emma T. Brentjens (17295999)

    Published 2023
    Subjects:
    Save to List
    Saved in:

Search Tools: